Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200563

CERIVASTATIN SODIUM
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+]
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL1200563
Name CERIVASTATIN SODIUM
Phase Approved
Structure Type MOL
InChI Key GPUADMRJQVPIAS-QCVDVZFFSA-M
Therapeutic ✓ Yes
Parent Compound CHEMBL1477
Active Moiety CHEMBL1477

Known Names

BAY W 6228 BAY-W-6228 Baycol Cerivastatin sodium Cerivastatin sodium salt
4
Targets
16
Activities
2
Assay Types
0
PK Parameters
12
Publications
5
Known Names
1
Mechanisms

Molecular Properties

459.6
MW (Da)
4.88
ALogP
5
HBA
3
HBD
99.9
PSA (Ų)
0.44
QED
0
Ro5 Violations
11
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1997
Availability Withdrawn
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Withdrawn
USAN Stem -stat-
USAN Year 1996

Extended Properties

Molecular Formula C26H33FNNaO5
MW 481.54
Aromatic Rings 2
Heavy Atoms 33
NP-Likeness 0.33

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
HMG-CoA reductase inhibitor INHIBITOR 3-hydroxy-3-methylglutaryl-coenzyme A reductase ✓ ✓

Drug Warnings

Withdrawn
musculoskeletal toxicity
increased risk of rhabdomyolysis
Country: Worldwide   Year: 2001
Withdrawn
nephrotoxicity
Rhabdomyolysis _ kidney failure and muscle damage
Country: Worldwide   Year: 2001

Activity Summary

IC50 12 meas. best 7.28
EC50 4 meas. best 6.47

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
 IC50 7.28 6.334 52.9 10
Unchecked
CHEMBL612545
 EC50 6.47 6.47 338.0 1
BJ
CHEMBL614358
 EC50 6.47 6.46 339.0 3
A2780
CHEMBL614004
 IC50 6.16 6.16 700.0 1
NCI-H460
CHEMBL396
 IC50 5.46 5.46 3500.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 52.91 nM 7.28 PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50. (... -
Unchecked IC50 = 89.4 nM 7.05 PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area de... -
Unchecked IC50 = 143.28 nM 6.84 PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50. (Class of assay: co... -
Unchecked IC50 = 240.31 nM 6.62 PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50. (Class of assay: c... -
Unchecked IC50 = 259.0 nM 6.59 PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (vi... -
Unchecked EC50 = 338.0 nM 6.47 PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compound... -
BJ EC50 = 339.0 nM 6.47 PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compound... -
BJ EC50 = 347.0 nM 6.46 PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Comp... -
BJ EC50 = 356.0 nM 6.45 PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compound... -
A2780 IC50 = 700.0 nM 6.16 Antiproliferative activity against human A2780 cells incubated for 4 days by MTT... 31803394
Unchecked IC50 = 1013.05 nM 5.99 PubChem BioAssay. RKO viability from Cell TiterGlo-IC50. (Class of assay: conf... -
Unchecked IC50 = 1211.61 nM 5.92 PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50. (Class of assay: co... -
Unchecked IC50 = 1873.3 nM 5.73 PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50. (Class of assay: c... -
Unchecked IC50 = 1924.47 nM 5.72 PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50. (Class of assay: ... -
Unchecked IC50 = 2506.51 nM 5.6 PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50. (Class of assay: co... -
NCI-H460 IC50 = 3500.0 nM 5.46 Antiproliferative activity against human H460 cells incubated for 4 days by MTT ... 31803394

Literature References

PubMed DOI Target Context # Activities
20014752 10.1021/tx900326k Hepatotoxicity 3
31803394 10.1039/C9MD00227H Unchecked 2
31803394 10.1039/C9MD00227H A2780 1
31803394 10.1039/C9MD00227H NCI-H460 1
- 10.6019/CHEMBL4513141 Candida albicans 1
- 10.6019/CHEMBL4513141 Cryptococcus neoformans 1
- 10.6019/CHEMBL4513141 Escherichia coli 1
- 10.6019/CHEMBL4513141 Klebsiella pneumoniae 1
- 10.6019/CHEMBL4513141 Pseudomonas aeruginosa 1
- 10.6019/CHEMBL4513141 Acinetobacter baumannii 1
- 10.6019/CHEMBL4513141 Staphylococcus aureus 1
- 10.6019/CHEMBL4513141 HEK293 1

Data from ChEMBL 36 via Core Engine